-
IntroducedApr 14, 2026
-
Passed House
-
Passed Senate
-
Became Law
United States House Bill
To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.
Last Action See all actions
House • Apr 14, 2026: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
Comments on HR 8269
Tweets
Whip Lists
Sponsors
Votes
Actions
- Apr 14, 2026 | House
- Introduced in House
- Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill Texts
Documents

